Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer talked about. Cramer discussed the company’s IPO and its performance to date, as he remarked:
“But again, the fact that the IPO market was able to mostly self-correct in these situations and stamp out the froth, that’s what we really like, it’s a good thing for stocks in general. Just after Fermi came public, the IPO market went quiet for a while, thanks to the government shutdown that forced a much-needed cooling-off period for the IPO market, was good for us. After the government reopened, we ended up getting the largest deal in four years when Medline came public. Now, this is a medical supplies distributor and a medical device maker, highly thought of in the industry. Medline priced its IPO at $29, and the stock jumped to $41 on its first day of trading. Now, it’s just at 40 bucks and change. Now, this seems pretty healthy to me, and it’s a terrific company, and if the stock comes in, it’s a buy.”
Photo by Artem Podrez on Pexels
Medline Inc. (NASDAQ:MDLN) supplies medical and surgical products for hospitals, surgery centers, and other healthcare facilities.
While we acknowledge the potential of MDLN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
